Simon Roitt, Ph.D.

Simon is a clinical scientist with more than 25 years’ extensive experience in clinical development and clinical operations. He has held a number of global clinical development operation leadership roles at Roche, Astra Zeneca, and Eli Lilly, as well as in biotech clinical stage companies in oncology, medical devices, radiopharmaceuticals and genetic profiling. With a keen interest in rare diseases, Simon is passionate about developing medicines for patients for whom few, if any, therapeutic options exist. He holds a PhD in neuroimmunology and biochemistry from the University of York in the UK and a Diploma in Clinical Science from the University of Wales. Simon self-admittedly has too many hobbies, including music, traveling, sailing, learning new languages, and building model boats and trains.